Simon Read
Director · 3 filings · Latest: Aug 19, 2026
Dianthus Therapeutics, Inc. /DE/
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DNTH | Simon Read | Director | Aug 19, 2026 | Sale | $117.55 | 2,778 | $326.6K | 0 | |
DNTH | Simon Read | Director | Aug 19, 2026 | Option Exercise | $18.36 | 2,778 | $51.0K | 2,778 | |
DNTH | Simon Read | Director | Aug 10, 2026 | Sale | $109.55 | 2,777 | $304.2K | 0 | |
DNTH | Simon Read | Director | Aug 10, 2026 | Option Exercise | $18.36 | 2,777 | $51.0K | 2,777 | |
DNTH | Read Simon | — | Aug 10, 2026 | Proposed Sale | $112.50 | 5,550 | $624.4K | — |